B
Biofourmis
Biotechnology company that augments personalized care and therapies using digital therapeutics
At a glance
- Founded
- 2015
- Headquarters
- Boston, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
- EIEden Strategy Institute
- SPSpesNet Pte.
Series A2 investors entered at this stage
- OVOpenspace Ventures
- AVAviva Ventures
Series B and later10 investors entered at this stage
Sequoia- CHCVS Health
- JCJinke Entertainment Culture
General Atlantic
SoftBank Vision Fund- MVMassMutual Ventures
- EDEDBI
Intel Capital
SoftBank- SGSGInnovate
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Investments and acquisitions
Disclosed deals where Biofourmis was the backer or acquirer, 2019–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Biofourmis's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Biofourmis's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biofourmis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biofourmis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.